Disclaimer: Product Under Development. Subject to FDA Clearance
About Cern Corporation
The CERN DEVICE™ will be a REVOLUTION!
A non-drug solution to Bacterial Vaginosis and Yeast infections
The Cern Device: the Game-Changing Product, women have been waiting for
The Cern Device™ is intended for use at home, when needed, as needed, based on familiar, recurrent symptoms, helping to avoid repeated visits to a physician. Our goal? Effective treatment for BOTH yeast and bacterial indications at home, without toxic, systemic drugs!
Shaped and sized similar to a tampon, the Cern Device™, inserted for 30-60 minutes, is designed to effectively control both bacterial and or fungal infections (which often occur simultaneously) while maintaining appropriate levels of key native bacteria and yeast which are essential for a healthy microbiome.
Add Your Heading Text Here
You Are Not Alone!
According to the Center for Disease Control, in the United States alone, there are over 9 million women who are under a physician’s care for treatment of Recurrent VulvoVaginal Candidiasis (Known as RVVC or Recurrent Yeast infection, defined as 4+ occurrences per year) as well as Bacterial Vaginosis (BV).
The “issue” with these statistics is only RVVC/Recurrent is tracked. Doctors tell us, women seek clinical care after only a single incidence. With regard to Bacterial Vaginosis, BV is symptomatic in perhaps 16% of those afflicted? So what does this all mean? It means the afflicted population may be significantly under-reported and that there are so many more women for whom The Cern Device may be the answer. Especially those who may want or need to reduce drug intake as they may be immunocompromised or suffer issues from use of various antifungal, antibiotic medications.
Video Insights
Cern Corporation was formed to develop and commercialize what may be an effective treatment for fungal and bacterial vaginosis using low-level microbicidal light. Cern’s team includes significant scientists, clinicians as well as healthcare leaders, aligned to address a significant “Unmet Need” in women’s health focused on the treatment of yeast and bacterial vaginosis without the use of systemic antifungal/antibiotics.
